NYT: Reject The White House's Deal With Big Pharma

03/18/2010 05:12 am ET | Updated May 25, 2011
  • New York Times

The drug industry has been ramping up its prices in advance of any health care reforms that might clamp down on its profits. The industry's rapid price escalation over the past year threatens to make a mockery of its deal with the Senate Finance Committee and the Obama administration to contribute $80 billion over the next decade to help pay for covering tens of millions of uninsured Americans.

The industry's contribution will consist of drug discounts to certain Medicare beneficiaries, larger rebates on drugs bought for Medicaid beneficiaries and new fees on the industry.

Read more on New York Times